Aguirre Ana Julia, Apiquián Rogelio, Fresán Ana, Cruz-Fuentes Carlos
Departamento de Genética Psiquiátrica, Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría "Ramón de la Fuente", Calzada México-Xochimilco 101, Col. San Lorenzo Huipulco, cp 14370 D.F., México.
Psychiatry Res. 2007 Dec 3;153(3):209-15. doi: 10.1016/j.psychres.2006.12.011. Epub 2007 Sep 5.
In this study, we investigated whether polymorphisms of the dopamine D4 receptor (DRD4) gene were associated with psychotic symptomatology rather than with a unique diagnosis such as schizophrenia. A number of association studies between the DRD4 gene 48 bp-VNTR polymorphism at exon 3 and psychotic disorders have been reported, but the results have been controversial. Both 48 bp-VNTR and the 12 bp-VNTR (at exon 1) polymorphisms of this gene were analyzed in a group of 149 unrelated Mexican subjects with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, major depression and bipolar disorder, both with psychotic symptoms, brief psychotic disorder, delusional disorder and non-specific psychotic disorder, and in 169 individuals free of psychiatric illnesses. There were no differences in allele or genotype frequencies between groups for the 12 bp-VNTR polymorphisms. However, a significant excess of "rare" alleles (3-, 5-, 6- and 8-48 bp repeats alleles) was found in the group of psychotics. Moreover, haplotypes 3-A1, 5-A1, 6-A1 and 8-A1 were significantly more frequently associated with cases. This positive association supports a role of this molecule as a genetic risk factor in psychotic disorders.
在本研究中,我们调查了多巴胺D4受体(DRD4)基因多态性是否与精神病性症状相关,而非与诸如精神分裂症等单一诊断相关。已有多项关于DRD4基因第3外显子48 bp可变数目串联重复序列(VNTR)多态性与精神障碍之间的关联研究报道,但结果存在争议。我们对149名无亲缘关系的墨西哥受试者进行了分析,这些受试者被诊断为精神分裂症、分裂情感性障碍、精神分裂症样障碍、伴有精神病性症状的重度抑郁症和双相情感障碍、短暂精神病性障碍、妄想性障碍以及非特异性精神病性障碍,同时纳入了169名无精神疾病的个体,分析了该基因的48 bp-VNTR和12 bp-VNTR(第1外显子)多态性。两组之间12 bp-VNTR多态性的等位基因或基因型频率没有差异。然而,在精神病患者组中发现“罕见”等位基因(3-、5-、6-和8-48 bp重复等位基因)显著过量。此外,单倍型3-A1、5-A1、6-A1和8-A1与病例的关联显著更频繁。这种正相关支持了该分子作为精神障碍遗传风险因素的作用。